Arthritis Drug Olumiant Helped 1 In 3 Alopecia Patients Regrow Hair
That’s the main finding of a new study published in The New England Journal of Medicine that analyzed the impact of Olumiant (baricitinib), which is in a class of medications known as Janus kinase (JAK) inhibitors, on patients with alopecia areata. The study featured the results of two clinical trials featuring a total of 1,200 patients with severe alopecia areata. The patients were randomly assigned to receive a once-daily dose of 4 milligrams (mg) of Olumiant, a 2mg dose of Olumiant, or a placebo and monitored for 36 weeks....